Published in Pharma Law Weekly, January 18th, 2005
The Protos DR/CLS, manufactured and legally marketed by Biotronik, Inc., offers the unique Closed Loop Stimulation (CLS) method of rate-adaptive pacing therapy.
This device is the first implant for a randomized three-arm clinical investigation designed to demonstrate efficacy of both the Stratos LV and the Protos DR/CLS pacemakers in CHF patients who have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.